诉讼核心信息 - 投资者权利律师事务所Hagens Berman提醒Inspire Medical Systems, Inc. (NYSE: INSP)的投资者注意一项待决的证券集体诉讼[1] - 诉讼指控Inspire Medical及其高管在推出新一代设备Inspire V时隐瞒了关键运营失败从而误导了投资者[1] - 集体诉讼期涵盖在2024年8月6日至2025年8月4日期间购买Inspire Medical (INSP)证券的投资者[2] - 首席原告截止日期为2026年1月5日[3] 指控的核心内容 - 公司曾向投资者保证其已做好Inspire V发布的“运营准备”并准备好进行全面商业推广[3] - 指控称这些保证掩盖了根本性的失败导致发布不可能成功并引发了灾难性的业绩指引削减和股价暴跌[3] - 据称未披露的运营问题使公司的声明在重大方面存在虚假和误导性[4] 具体指控的运营问题 - **医疗保险与计费准备不足**：处理医疗保险索赔所需的软件更新直到2025年7月1日才生效这意味着植入中心无法为手术计费阻碍了早期采用[4] - **旧型号库存过剩**：客户和治疗中心持有大量旧款Inspire IV设备库存影响了新款Inspire V产品的需求并需要进行库存“清理”[4] - **培训与入职不完善**：“许多中心”未完成植入新设备所需的基本培训、合同签订和入职流程[4] 指控的财务与市场影响 - 据称有缺陷的Inspire V发布导致公司将其2025年每股收益(EPS)指引削减了超过80%[4] - 这些问题导致股价单日下跌42.04美元市值缩水32.4%[4] - 律师事务所调查的重点是据称被隐瞒的两个关键点：医疗保险索赔软件故障和旧款Inspire IV设备的库存过剩[5] - 诉讼指控Inspire的股价崩盘是管理层据称优先考虑无缝过渡的叙事而非运营现实的结果[5]

诉讼核心指控 - 公司及其高管被指控违反联邦证券法 发布虚假和/或误导性陈述 和/或未能披露关于Inspire V的关键事实 包括该设备的真实市场需求以及公司是否已采取成功推出所需的步骤 [2] - 被告发布了一系列重大虚假和误导性陈述 让投资者相信Inspire V需求强劲且公司已为成功推出采取必要步骤 [2] Inspire V设备推出受挫详情 - 2025年8月4日 公司宣布其新Inspire V设备的推出遭遇重大挫折 [3] - 推出耗时远超预期 原因是许多治疗中心尚未完成使用该产品所需的培训、合同签订和准备工作 [3] - 公司披露了计费和报销方面的挑战 尽管医疗保险已批准Inspire V的CPT代码 但索赔处理所需的软件更新直到7月1日才生效 [3] - 因此 植入中心在该日期之前无法对手术进行计费 转而继续使用旧的Inspire IV系统 [3] 财务与市场影响 - Inspire V推出还面临需求疲软和库存过剩的问题 [4] - 这些问题迫使公司将2025年收益指引大幅下调超过80% [4] - 消息披露后 公司股价在单日内下跌超过32% 从2025年8月4日的每股129.95美元跌至2025年8月5日的每股87.91美元 [4] - 此次股价下跌导致市值蒸发约12亿美元 [4]

集体诉讼案件概述 - 律师事务所Levi & Korsinsky, LLP通知Inspire Medical Systems, Inc. (NYSE: INSP)的投资者，公司面临一起集体诉讼证券案件 [1] - 该诉讼旨在为在2024年8月6日至2025年8月4日期间因涉嫌证券欺诈而遭受不利影响的投资者挽回损失 [1] - 投资者若在此时间段内遭受损失，需在2026年1月5日前请求法院指定其为首席原告 [3] 诉讼指控的核心内容 - 指控称，被告做出了虚假陈述和/或隐瞒了事实，即公司新产品Inspire V的发布是一场灾难，因为市场需求疲软，且供应商拥有大量过剩库存，不愿转向新疗法 [2] - 指控称，与公司向投资者保证已采取所有必要措施确保成功发布、且发布进展顺利的陈述相反，公司未能完成发布所需的基本准备工作 [2] - 具体指控的失败包括：未能为“许多”治疗中心客户完成培训和入职；未能建立基本的IT系统，包括客户审批流程；未能确保关键的保险公司理赔软件得到适当更新以促进理赔处理和支付；以及未能在发布时确保医疗保险报销到位 [2] 律师事务所背景信息 - Levi & Korsinsky律师事务所在过去20年中，已为受损股东追回数亿美元（hundreds of millions of dollars），并建立了赢得高风险案件的记录 [4] - 该事务所在代表投资者处理复杂证券诉讼方面拥有丰富专业知识，拥有超过70名员工的团队为客户服务 [4] - 该事务所连续七年被ISS Securities Class Action Services评为美国顶级证券诉讼公司之一 [4]

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical- ...

NEW YORK, Dec. 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingenc ...

Inspire's Alleged Fraud NEW YORK--(BUSINESS WIRE)--Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G†) filed a class action in the U.S. District Court for the Southern District of New York alleging violations of the federal securities laws by Inspire Medical Systems, Inc. ("Inspire†or the "Company†) and certain of the Company's current senior executives (collectively, "Defendants†). The action is brought on behalf of all investors who purchased or otherwise ...

NEW YORK, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Inspire securities between August 6, 2024 and August 4, 2025, b ...

Key Takeaways INSP records strong Inspire V adoption, with most implanting centers trained and already using the new system.Inspire Medical expects to improve reimbursement, including an 11% CMS physician fee increase starting in 2026INSP faces near-term pressure from inventory transition, GLP-1 trialing delays, and elevated operating costs.Inspire Medical Systems (INSP) is well poised for growth in the coming quarters amid a major product transition. Management emphasized clinical momentum behind Inspire V ...

New York, New York--(Newsfile Corp. - December 22, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ ...

NEW YORK, Dec. 22, 2025 /PRNewswire/ --The Gross Law Firm issues the following notice to shareholders of Inspire Medical Systems, Inc. (NYSE: INSP). The Gross Law Firm 15 West 38th Street, 12th floor New York, NY, 10018 Email: [email protected] Phone: (646) 453-8903 ALLEGATIONS: According to the filed complaint, defendants made false statements and/or concealed that: In truth, the launch of the Company's new product, Inspire V, was a disaster because demand for Inspire V was poor, as providers had significa ...